Skip to content

Cortical excitability in patients with amyotrophic lateral sclerosis (ALS): a study based on transcranial magnetic stimulation (TMS)

Regulation test of Transcranial Magnetic Stimulation for Neurological Disorders - Regulation test of TMS for Neurological Disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079279
Enrollment
Unknown
Registered
2023-12-29
Start date
2022-08-17
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyotrophic lateral sclerosis

Interventions

Amyotrophic Lateral Sclerosis Group:NA

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient Inclusion Criteria: 1.Patients who possess independent civil conduct capabilities and have given informed consent for this study. 2.Patients who meet the revised El Escorial criteria and are definitively or potentially diagnosed with ALS. 3.Patients initially diagnosed as potentially having ALS, including those confirmed to have ALS during the study period. Healthy Control Inclusion Criteria: 1.Individuals with independent civil conduct capabilities who have given informed consent for this study. 2.Age approximately matching that of the ALS patients included (within 5 years), with the same gender ratio.

Exclusion criteria

Exclusion criteria: Patient Exclusion Criteria: 1.Patients with progressive muscular atrophy and primary lateral sclerosis. 2.Patients in poor general condition or with cardio-pulmonary diseases that prevent them from completing examinations. 3.Patients with other neurological diseases or contraindications for transcranial magnetic stimulation, such as a cardiac pacemaker. Healthy Control Exclusion Criteria: 1.Individuals with other neurological diseases or contraindications for transcranial magnetic stimulation, such as a cardiac pacemaker. 2.Poor general condition or with cardio-pulmonary diseases that prevent them from completing examinations.

Design outcomes

Primary

MeasureTime frame
short-interval intracortical inhibition(SICI);

Secondary

MeasureTime frame
ALSFR Scale;ECAS Scale;

Countries

China

Contacts

Public ContactXiao Fei

The First Affiliated Hospital of Chongqing Medical University

xiaofei_clinreg@163.com+86 23 8901 2009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026